Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro assays, probiogenomic analysis, safety assessment and probiotic potential of Enterococcus faecium F25.

Scientific reports·2026
Same author

Heat transfer analysis on a stretching cylinder with Williamson hybrid nanofluid: effects of convective boundary conditions, Darcy-Forchheimer resistance, and Cattaneo-Christov heat Flux.

Discover nano·2026
Same author

Genetic services in Pakistan: a review highlighting limitations and opportunities for improvement.

Journal of community genetics·2026
Same author

Synergistic effects of salicylic acid based plant growth regulators on growth, photosynthetic performance, and antioxidant defense of Polianthes tuberosa L. under drought stress.

Scientific reports·2026
Same author

Pseudomonas aeruginosa ST4936 with extensive antibacterial drug resistance and virulence determinants from ureteral stent biofilms: whole-genome insights.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Tick-borne diseases in Illinois (USA): A retrospective case analysis.

Ticks and tick-borne diseases·2026

Related Experiment Video

Updated: Jun 4, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Hepatitis associated aplastic anemia: a review.

Bisma Rauff1, Muhammad Idrees, Shahida Amjad Riaz Shah

  • 1Division of Molecular Biology, National Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, 87 West Canal Bank Road, Thokar Niaz Baig, Lahore 53700, Pakistan.

Virology Journal
|March 1, 2011
PubMed
Summary

Hepatitis-associated aplastic anemia (HAAA) is a severe condition in children following hepatitis, often caused by viruses and immune system dysfunction. Early diagnosis and treatments like bone marrow transplant are crucial for survival.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Area of Science:

  • Hematology
  • Virology
  • Immunology

Background:

  • Hepatitis-associated aplastic anemia (HAAA) is a rare but serious complication following acute hepatitis.
  • It predominantly affects young male children and can be fatal if untreated.
  • The condition is characterized by pancytopenia appearing months after hepatitis onset.

Purpose of the Study:

  • To explore the diverse etiologies of Hepatitis-associated aplastic anemia (HAAA).
  • To elucidate the immunopathogenesis and genetic factors contributing to HAAA.
  • To review diagnostic criteria and therapeutic strategies for HAAA.

Main Methods:

  • Review of clinical features, viral serological markers, and immune system analysis.
  • Examination of bone marrow hypocellularity.
  • Analysis of treatment outcomes for bone marrow transplantation versus immunosuppressive therapy.

Main Results:

  • HAAA is linked to various hepatitis viruses (HAV, HBV, HCV, HDV, HEV, HGV) and other viruses (e.g., parvovirus B19, CMV, EBV, TTV).
  • Evidence strongly suggests an immune-mediated mechanism, with no association found with transfusions, drugs, or toxins.
  • Telomerase mutation is also identified as a potential predisposing genetic factor.

Conclusions:

  • HAAA diagnosis relies on clinical presentation, blood tests, viral markers, immune function, and bone marrow examination.
  • Hematopoietic cell transplantation is the preferred treatment, especially for pancytopenia post-hepatitis.
  • Immunosuppressive therapy, augmented by steroids like glucocorticoids, serves as an alternative when transplantation is not feasible.